Myeloperoxidase-mediated solution demonstrates rapid virucidal properties against the delta variant of SARS-CoV-2
dc.contributor.author | Denys, G. A. | |
dc.contributor.author | Burningham, K. | |
dc.contributor.author | Dyba, J. | |
dc.contributor.author | Allen, R. C. | |
dc.contributor.author | Stephens , J. T., Jr. | |
dc.contributor.department | Microbiology and Immunology, School of Medicine | |
dc.date.accessioned | 2024-06-20T16:18:47Z | |
dc.date.available | 2024-06-20T16:18:47Z | |
dc.date.issued | 2022-05 | |
dc.eprint.version | Final published version | |
dc.identifier.citation | Denys, G. A., Burningham, K., Dyba, J., Allen, R. C., & Stephens, J. T. (2022). Myeloperoxidase-mediated solution demonstrates rapid virucidal properties against the delta variant of SARS-CoV-2. The Journal of Hospital Infection, 123, 189–190. https://doi.org/10.1016/j.jhin.2022.02.013 | |
dc.identifier.uri | https://hdl.handle.net/1805/41655 | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | |
dc.relation.isversionof | 10.1016/j.jhin.2022.02.013 | |
dc.relation.journal | Journal of Hospital Infection | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | SARS-CoV-2 | |
dc.subject | COVID-19 pandemic | |
dc.subject | mitigation | |
dc.subject | myeloperoxidase-mediated solution (MPMS) | |
dc.title | Myeloperoxidase-mediated solution demonstrates rapid virucidal properties against the delta variant of SARS-CoV-2 | |
dc.type | Article | |
ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864890/ |